These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7898571)

  • 21. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
    Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
    Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The advantage of gastrectomized patients in management of their chronic hepatitis C.
    Hayashi H; Takikawa T; Arai N; Yano M
    Nagoya J Med Sci; 1997 Nov; 60(3-4):119-27. PubMed ID: 9481091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
    Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
    J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
    Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR
    Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].
    Kamar N; Sandres-Saune K; Selves J; Durand D; Izopet J; Rostaing L
    Nephrologie; 2003; 24(2):89-94. PubMed ID: 12723514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees.
    Bassett SE; Di Bisceglie AM; Bacon BR; Sharp RM; Govindarajan S; Hubbard GB; Brasky KM; Lanford RE
    Hepatology; 1999 Jun; 29(6):1884-92. PubMed ID: 10347134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
    Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
    Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
    Zeuzem S; Franke A; Lee JH; Herrmann G; Ruster B; Roth WK
    Hepatology; 1996 Nov; 24(5):1003-9. PubMed ID: 8903367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C.
    Hayashi H; Takikawa T; Nishimura N; Yano M
    J Hepatol; 1995 Mar; 22(3):268-71. PubMed ID: 7608476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.
    Iwasa M; Iwata K; Kaito M; Ikoma J; Yamamoto M; Takeo M; Kuroda M; Fujita N; Kobayashi Y; Adachi Y
    Nutrition; 2004 Apr; 20(4):368-71. PubMed ID: 15043853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of hepatitis C: other options.
    Bonkovsky HL
    Hepatology; 1997 Sep; 26(3 Suppl 1):143S-151S. PubMed ID: 9305680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
    Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
    Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
    Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
    Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
    Sheth SG; Flamm SL; Gordon FD; Chopra S
    Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.